Chief Executive Officer
CurrentWe are pleased to announce that we are introducing a range of AI tools for pharma, agencies and the public. These tools are built around the Retrieval Augmented Generation (RAG), which enables language models to be grounded in information specific to the application. The first application is AIMI, an assistant for specialists in medical information and pharmacovigilance.We have also launched a major innovation in adverse drug reaction management for clinicians and life science researchers called ADRx, an online drug safety system. ADRx provides instant access to curated information from the FDA's Adverse Event Reporting System (FAERS).